DUPD1 Inhibitors
Chemical inhibitors of DUPD1 function through various mechanisms to modulate the activity of the protein by interfering with different signaling pathways and enzymes that are responsible for its regulation. Bisindolylmaleimide I, for instance, is known to selectively inhibit protein kinase C (PKC), which can decrease DUPD1 activity if PKC is involved in its regulation. Similarly, staurosporine, a non-selective protein kinase inhibitor, can broadly inhibit kinases that may phosphorylate and activate DUPD1. Other kinase inhibitors like LY294002 and wortmannin specifically target phosphoinositide 3-kinases (PI3K), which, if part of DUPD1's regulatory pathway, would lead to reduced activation of the protein. Additionally, PD98059 and U0126, which inhibit mitogen-activated protein kinase kinase (MEK), and SB203580, an inhibitor of p38 MAP kinase, can decrease the activity of DUPD1 by preventing the phosphorylation signals from these MAPK-related pathways.
In a similar vein, SP600125, which inhibits c-Jun N-terminal kinase (JNK), and PP2, an inhibitor of Src family tyrosine kinases, can reduce DUPD1 activity by blocking the respective kinases that may be necessary for its activation. The mTOR pathway, another regulatory route for numerous proteins, can be inhibited by rapamycin, possibly leading to a decrease in DUPD1 activity. NF449, by selectively inhibiting Gs alpha subunit of G-proteins, can alter downstream signaling that may affect DUPD1. Lastly, Y-27632, which inhibits the Rho-associated protein kinase (ROCK), can lead to reduced DUPD1 activity if ROCK is involved in the regulation of DUPD1 functions. Each of these inhibitors targets specific kinases or pathways that, upon inhibition, can alter the functional state of DUPD1.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a potent and selective inhibitor of protein kinase C (PKC), which could diminish the activity of DUPD1 if DUPD1 is a substrate or is regulated by PKC-mediated phosphorylation. Inhibition of PKC could prevent DUPD1 from receiving phosphorylation signals, thereby reducing its activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a non-selective protein kinase inhibitor. If DUPD1 activity is dependent on phosphorylation by kinases, staurosporine would inhibit these kinases, thus preventing the phosphorylation and activation of DUPD1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of phosphoinositide 3-kinases (PI3K). If the signaling pathway involving PI3K is upstream of DUPD1 and regulates its activity, inhibition of PI3K may result in reduced phosphorylation and activation of DUPD1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor. It functions similarly to LY294002, by potentially reducing the phosphorylation and subsequent activation of DUPD1 if it is downstream of PI3K signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of mitogen-activated protein kinase kinase (MEK). If DUPD1 is regulated by the ERK/MAPK pathway, PD98059 would inhibit MEK, thereby preventing activation of ERK/MAPK and subsequent regulation of DUPD1 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAP kinase. Inhibition of p38 MAP kinase could reduce DUPD1 activity if DUPD1 is regulated by stress-activated protein kinase pathways that involve p38 MAPK. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). Inhibiting JNK could lead to decreased DUPD1 activity if DUPD1 is regulated by pathways involving JNK signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of MEK1/2. If DUPD1 is part of the ERK/MAPK pathway, U0126 would inhibit MEK1/2, preventing the activation of MAPK/ERK and potentially reducing DUPD1 activity. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases. If DUPD1 is activated by Src family kinases, PP2 would inhibit these kinases, possibly leading to a decrease in DUPD1 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. If DUPD1 is part of a pathway regulated by mTOR, inhibition of mTOR could lead to reduced activity of DUPD1. | ||||||